Wojciech G. Polak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wojciech G. Polak has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Andrzej Gładysz
2 shared publicationsP. Szyber
Department of Vascular, General and Transplant Surgery, Wroclaw Medical University, Wroclaw, Poland
2 shared publicationsBalazs A. Nemes
Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Groningen University Medical Center, The Netherlands
1 shared publicationD Patrzalek
Department of Vascular, General & Transplantation Surgery, Medical University in Wroclaw, Wroclaw, Poland
1 shared publicationD. Janczak
Department of Vascular, General and Transplantation Surgery, Medical Academy in Wroclaw, Poland
1 shared publicationD. Jezior
Department of Nephrology and Transplant Medicine, Wroclaw Medical University, Wroclaw, Poland
1 shared publication
Latest Publications
- 1 January 2006
- Published by Elsevier in Transplantation Proceedings
- Vol. 38 (1) , 131-132
Incidence and Outcome of Transplant Renal Artery Stenosis: Single Center Experience
- 1 January 2006
- Published by Elsevier in Transplantation Proceedings
- Vol. 38 (1) , 131-132
Incidence and Outcome of Transplant Renal Artery Stenosis: Single Center Experience
- Open Access
- 20 July 2005
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 11 (8) , 934-940
Sequential and simultaneous revascularization in adult orthotopic piggyback liver transplantation
The aim of the study was to assess whether there is a difference in outcome after sequential or simultaneous revascularization during orthotopic liver transplantation (OLT) in terms of patient and graft survival, mortality, morbidity, and liver function. The study population consisted of 102 adult patients with primary full-size piggyback OLT transplanted between January 1998 and December 2001. In 71 patients (70%) the grafts were sequentially reperfused after completion of the portal vein anastomosis and subsequent arterial reconstruction was performed (sequential reperfusion [SeqR] group). In 31 patients (30%) the graft was reperfused simultaneously via the portal vein and hepatic artery (simultaneous reperfusion [SimR] group). Patient and graft survival at 1, 3, and 6 months and at 1 year did not differ between the SeqR group and the SimR group. The red blood cell (RBC) requirements were significantly higher in the SimR group (5.5 units; range 0-20) in comparison to the SeqR group (2 units; range 0-19) ( P = 0.02). Apart from a higher number of biliary anastomotic complications and abdominal bleeding complications in the SimR group in comparison to the SeqR group (13% vs. 2% and 19% vs. 6%, respectively; P = 0.06), morbidity was not different between the groups. No differences between the groups were observed regarding the incidence of primary nonfunction (PNF), intensive care unit stay, and acute rejection. This was also true for the severity of rejections. Postoperative recuperation of liver function was not different between the groups. In conclusion, no advantage of either of the 2 reperfusion protocols could be observed in this analysis, especially with respect to the incidence of ischemic type biliary lesions (ITBL). (Liver Transpl 2005;11:934–940.)
- 20 July 2005
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 11 (8) , 934-940
Open AccessSequential and simultaneous revascularization in adult orthotopic piggyback liver transplantation
The aim of the study was to assess whether there is a difference in outcome after sequential or simultaneous revascularization during orthotopic liver transplantation (OLT) in terms of patient and graft survival, mortality, morbidity, and liver function. The study population consisted of 102 adult patients with primary full-size piggyback OLT transplanted between January 1998 and December 2001. In 71 patients (70%) the grafts were sequentially reperfused after completion of the portal vein anastomosis and subsequent arterial reconstruction was performed (sequential reperfusion [SeqR] group). In 31 patients (30%) the graft was reperfused simultaneously via the portal vein and hepatic artery (simultaneous reperfusion [SimR] group). Patient and graft survival at 1, 3, and 6 months and at 1 year did not differ between the SeqR group and the SimR group. The red blood cell (RBC) requirements were significantly higher in the SimR group (5.5 units; range 0-20) in comparison to the SeqR group (2 units; range 0-19) ( P = 0.02). Apart from a higher number of biliary anastomotic complications and abdominal bleeding complications in the SimR group in comparison to the SeqR group (13% vs. 2% and 19% vs. 6%, respectively; P = 0.06), morbidity was not different between the groups. No differences between the groups were observed regarding the incidence of primary nonfunction (PNF), intensive care unit stay, and acute rejection. This was also true for the severity of rejections. Postoperative recuperation of liver function was not different between the groups. In conclusion, no advantage of either of the 2 reperfusion protocols could be observed in this analysis, especially with respect to the incidence of ischemic type biliary lesions (ITBL). (Liver Transpl 2005;11:934–940.)
- 1 January 2005
- Vol. 10 (3) , 11-6
Prevention of hepatitis B recurrence after liver transplantation.
Over the last decade significant improvement in patient and graft survival has been observed after liver transplantation for hepatitis B virus (HBV)-related liver disease, mostly because of efficient prophylaxis against hepatitis B reinfection. This review discusses different approches in prevention of hepatitis B recurrence in liver recipients including new concepts as vaccination against hepatitis B after liver transplantation. Based on available data combined prophylaxis with hepatitis B immunoglobulin (HBIG) and lamivudine is currently recommended prophylaxis for HBV recurrence after liver transplantation.
- 1 January 2005
- Vol. 10 (3) , 11-6
Prevention of hepatitis B recurrence after liver transplantation.
Over the last decade significant improvement in patient and graft survival has been observed after liver transplantation for hepatitis B virus (HBV)-related liver disease, mostly because of efficient prophylaxis against hepatitis B reinfection. This review discusses different approches in prevention of hepatitis B recurrence in liver recipients including new concepts as vaccination against hepatitis B after liver transplantation. Based on available data combined prophylaxis with hepatitis B immunoglobulin (HBIG) and lamivudine is currently recommended prophylaxis for HBV recurrence after liver transplantation.
- 1 January 2003
- Vol. 8 (4) , 16-21
Solid organ transplantation and HIV infection.
HIV infection has been traditionally considered to be an absolute contraindication for solid organ transplantation. Recent advances in HIV treatment, as highly active antiretroviral therapy (HAART), significantly reduced HIV-related mortality and morbidity. At the same time the number of HIV-infected patients with end-stage organ diseases constantly increased. Current data describing solid organ transplantation in HIV-infected patients demonstrated comparable outcome to that in the HIV-negative population. In light of this, solid organ transplantation should be considered as a treatment option for selected HIV-positive patients with end-stage organ disease.
- 1 January 2003
- Vol. 8 (4) , 16-21
Solid organ transplantation and HIV infection.
HIV infection has been traditionally considered to be an absolute contraindication for solid organ transplantation. Recent advances in HIV treatment, as highly active antiretroviral therapy (HAART), significantly reduced HIV-related mortality and morbidity. At the same time the number of HIV-infected patients with end-stage organ diseases constantly increased. Current data describing solid organ transplantation in HIV-infected patients demonstrated comparable outcome to that in the HIV-negative population. In light of this, solid organ transplantation should be considered as a treatment option for selected HIV-positive patients with end-stage organ disease.
- 1 March 2002
- Published by Elsevier in Transplantation Proceedings
- Vol. 34 (2) , 623-624
Underutilization of potential cadaveric liver donors
- 1 March 2002
- Published by Elsevier in Transplantation Proceedings
- Vol. 34 (2) , 623-624
Underutilization of potential cadaveric liver donors
- 1 May 2001
- Published by Hogrefe Publishing Group in Vasa
- Vol. 30 (2) , 138-140
Gefäßkomplikationen nach der Behandlung mit dem Ilizarov-Ringfixateur
Iatrogenic vascular injuries from external fixation in orthopaedics and traumatology are frequent. Three cases of vascular injuries after the treatment with Ilizarov external fixators were treated at our institution. These include two cases of pseudoaneurysms and one case of acute ischaemia of the lower limb. Two patients became symptomatic only after removal of the fixator. In all cases, the diagnosis was made by color flow duplex sonography. All vascular injuries needed surgical repair.
- 1 May 2001
- Published by Hogrefe Publishing Group in Vasa
- Vol. 30 (2) , 138-140
Gefäßkomplikationen nach der Behandlung mit dem Ilizarov-Ringfixateur
Iatrogenic vascular injuries from external fixation in orthopaedics and traumatology are frequent. Three cases of vascular injuries after the treatment with Ilizarov external fixators were treated at our institution. These include two cases of pseudoaneurysms and one case of acute ischaemia of the lower limb. Two patients became symptomatic only after removal of the fixator. In all cases, the diagnosis was made by color flow duplex sonography. All vascular injuries needed surgical repair.